The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Regulatory Update: Pending and New Guidance

Regulatory Update: Pending and New Guidance

Posted 01 March 2009

This draft guidance provides information on the development of animal efficacy models under the "Animal Rule" (21 CFR 314.600 for drugs; 21 CFR 601.90 for biologics). The Animal Rule is the means by which FDA marketing approval may be granted based on animal efficacy data when human efficacy testing is neither ethical nor feasible.

 

© 2021 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe